UPDATE -- embecta to Participate in Investor Conferences

PARSIPPANY, N.J., May 15, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world, today announced that management will participate in the following investor conferences:

2023 RBC Capital Markets Global Healthcare Conference

• Management will host a fireside session on Tuesday, May 16, 2023, at 3:05 p.m. Eastern Time (ET) at the InterContinental Barclay, New York. Audio webcasts of the presentations will be accessible under the “News & Events” section of the Company's investor relations website at investors.embecta.com.

2023 Jefferies Global Healthcare Conference

• Management will host a fireside session on Thursday, Jun 8, 2023, at 3:30 p.m. Eastern Time (ET) at the Marriott Marquis, New York. Audio webcasts of the presentations will be accessible under the “News & Events” section of the Company's investor relations website at investors.embecta.com.

2023 JMP Securities Mid-Year MedTech Forum

• Management will host one-on-one investor meetings on Thursday, June 22, 2023, at Four Seasons Hotel, Boston.

About embecta embecta is one of the largest pure-play diabetes care companies in the world, leveraging its nearly 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions, partnerships and the passion of approximately 2,000 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedIn, Facebook, Instagram and Twitter.

Contacts:

Media		Investors
Christian Glazar		Pravesh Khandelwal
Sr. Director, Corporate Communications		VP, Head of Investor Relations
908-821-6922		551-264-6547
Contact Media Relations		Contact IR

Source: Embecta Corp.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Crypto News Today: AlphaPepe Presale Nears Sellout With 11,000 Buyers While XRP Price Prediction Eyes $10
• Notice of Settlement of Shareholder Derivative Actions
• Simply Solventless Provides Update on Filing of 2025 Annual Financial Statements and Related Management's Discussion and Analysis and Management Cease Trade Order